Lupin receives FDA approval for generic Triamcinolone Acetonide Ointment Medical Dialogues Bureau23 Oct 2018 12:42 PM ISTNew Delhi: Pharma major Lupin announced that it has received approval for its Triamcinolone Acetonide Ointment USP, 0.1% from the United States Food...
GSK Pharma Q2 profit down 23 Percent to Rs 101 crore Medical Dialogues Bureau23 Oct 2018 10:03 AM ISTNew Delhi: GlaxoSmithKline(GSK)Pharmaceuticals has reported 22.67 per cent fall in standalone net profit to Rs 100.77 crore for the quarter ended...
IAVI Serum Institute to Develop Affordable Antibody Products for HIV Medical Dialogues Bureau23 Oct 2018 10:00 AM ISTNew Delhi: The International AIDS Vaccine Initiative (IAVI) and Serum Institute of India, the world's largest vaccine manufacturer, today announced a...
Strides Pharma gets USFDA approval for Gabapentin capsules Medical Dialogues Bureau23 Oct 2018 9:10 AM ISTBanglore: Strides Pharmaceutical Science’s step-down wholly-own subsidiary, Strides Pharma Global, Singapore, has received approval for Gabapentin...
Unichem gets EIR from USFDA for Pithampur, Roha facilities Medical Dialogues Bureau23 Oct 2018 9:00 AM ISTNew Delhi: Drug firm Unichem Laboratories has recently announced its active pharmaceutical ingredient (API) manufacturing units at Pithampur and Roha...
Tata Iodised Salt urges the nation to pay attention to the missing “I” Medical Dialogues Bureau22 Oct 2018 3:24 PM IST“I” is the symbol for the element Iodine. According to WHO, iodine deficiency in foetal life and early childhood remains the single most important and...
Lupin antimyotonic agent receives positive opinion from EMA Medical Dialogues Bureau22 Oct 2018 1:48 PM ISTNaMuscla is an antimyotonic agent which is under review by the European Medicines Agency to treat symptomatic myotonia in adults with non-dystrophic...
J&J hip implants: Affected patients seek clarity on report on compensation amount Medical Dialogues Bureau22 Oct 2018 9:40 AM ISTNew Delhi: Amid reports that the victims of Johnson & Johnson's faulty hip implants are likely to get as much as Rs 1.2 crore each in...
AstraZeneca Lynparza shown to put brakes on ovarian cancer Medical Dialogues Bureau22 Oct 2018 9:20 AM ISTMUNICH - An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a...
Lupin gets USFDA nod for psoriasis treatment spray Medical Dialogues Bureau22 Oct 2018 9:03 AM ISTNew Delhi: Drug major Lupin today said it has received approval from the US health regulator to market Desoximetasone Topical spray, used for...
Merck KGaA says might strike partnership deal this year Medical Dialogues Bureau22 Oct 2018 9:00 AM ISTMUNICH: German drugmaker Merck KGaA might agree on partnership deals to jointly develop two of its most promising experimental medicines with a rival...
Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets Medical Dialogues Bureau21 Oct 2018 11:01 AM ISTNew Delhi: Jubilant Cadista Pharmaceuticals Inc, is recalling over 1.58 lakh bottles of Pantoprazole Sodium delayed-release tablets manufactured by...
